东星医疗：2025年第三次临时股东会决议公告

Group 1 - The core point of the article is that Dongxing Medical announced the approval of several proposals at its third extraordinary general meeting of shareholders in 2025, including the use of part of its idle raised funds and self-owned funds for cash management [2] Group 2 - The announcement indicates a strategic move by the company to optimize its financial resources [2] - The decision reflects the company's ongoing efforts to enhance its capital management practices [2]